Yescarta Receives Broader FL Label Than Breyanzi; MZL Not Granted in Yescarta's ZUMA-5 Accelerated Approval
Here is a brief preview of this blast: New content: The Celltelligence team has updated their CD19 CAR-T indications table for estimated approvals and submissions following Gilead’s (Kite) announcement (see below for download).